Tvito, Ariella <br/><br/>
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia.  [electronic resource] 

 -  Expert opinion on biological therapy  12 2017 
 - 1557-1564 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1080/14712598.2017.1387244  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--chemistry<br/>Antineoplastic Agents--chemistry<br/>Clinical Trials as Topic<br/>Half-Life<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Inotuzumab Ozogamicin<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prognosis